JSCOX
Price
$27.43
Change
-$0.04 (-0.15%)
Updated
Jul 31 closing price
Net Assets
1.27B
UBVVX
Price
$89.26
Change
-$0.55 (-0.61%)
Updated
Jul 31 closing price
Net Assets
9.02B
Interact to see
Advertisement

JSCOX vs UBVVX

JSCOX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
JSCOX vs. UBVVX commentary
Aug 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSCOX is a Hold and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.02B vs. JSCOX (1.27B). UBVVX pays higher dividends than JSCOX: UBVVX (1.59) vs JSCOX (0.37). JSCOX was incepted earlier than UBVVX: JSCOX (17 years) vs UBVVX (9 years). JSCOX (1.12) is less costly to investors than UBVVX (0.94). JSCOX is a more actively managed with annual turnover of: 37.00 vs. UBVVX (35.00). UBVVX has a lower initial minimum investment than JSCOX: UBVVX (0) vs JSCOX (2500). JSCOX annual gain was more profitable for investors over the last year : 25.16 vs. UBVVX (9.60). UBVVX return over 5 years is better than : 18.82 vs. JSCOX (16.83).
JSCOXUBVVXJSCOX / UBVVX
Total Expense Ratio1.120.90124%
Annual Report Gross Expense Ratio1.120.94119%
Fund Existence17 years9 years-
Gain YTD16.74514.187118%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B9.02B14%
Annual Yield % from dividends0.371.5923%
Returns for 1 year25.169.60262%
Returns for 3 years17.8114.27125%
Returns for 5 years16.8318.8289%
Returns for 10 years46.66N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDMIX22.160.82
+3.84%
Lazard Developing Markets Equity Instl
BFGBX39.090.60
+1.56%
BlackRock Capital Appreciation K
OIEFX27.750.23
+0.84%
JPMorgan Equity Income R2
GTLOX23.840.06
+0.25%
Glenmede Disciplined US Eq Ptf
GTMUX24.78-0.03
-0.12%
Goldman Sachs Small/Mid Cap Growth R6